COVID-19 vaccines are effective in people with obesity: A position statement from The Obesity SocietyCOVID-19 백신은 비만인에게 효과적입니다: 비만 학회의 입장 성명Article Published on 2021-10-012022-09-11 Journal: Obesity (Silver Spring, Md.) [Category] SARS, 변종, 임상, [키워드] authorization B.1.351 cause COVID-19 COVID-19 vaccine COVID-19 vaccines death demonstrated determine doses drug effective Efficacy elapsed Emergency Emergency use evaluated Evidence food Hospitalization inquiry Johnson & Johnson Moderna not significantly different obesity outcome measure outcome measures patients peer-reviewed Pfizer-BioNTech Phase 3 trials SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants scientific evidence Society South Africa submitted subpopulation Trial undergo US Food and Drug Administration vaccination Vaccine virus [DOI] 10.1002/oby.23251 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting실제 환경에서 고위험 인구의 SARS-CoV-2 백신 효과Article Published on 2021-10-012022-09-11 Journal: Annals of internal medicine [Category] SARS, 변종, [키워드] 95% CI Affair age BNT-162b2 body mass body mass index Care case-control study Comorbidities Department determine disease severity effective Effectiveness Emergency use authorization evaluate Follow-up Health Health care Health care system high-risk population Infection lack Logistic regression male median age Moderna Moderna mRNA-1273 vaccine Mortality mRNA-1273 Participants Pfizer Pfizer-BioNTech Population positive presence of comorbidities Propensity score remained routine clinical care SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination SARS-CoV-2 variant SARS-CoV-2 variants second dose setting Sex tested the median vaccination Vaccine veteran white [DOI] 10.7326/M21-1577 PMC 바로가기 [Article Type] Article
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesmRNA-1273은 비인간 영장류의 SARS-CoV-2 베타 감염으로부터 보호합니다Article Published on 2021-10-012022-09-11 Journal: Nature Immunology [Category] MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 airway Antibody neutralization Antibody titers B.1.351 B.1.617.2 Bronchoalveolar lavage coronavirus Critical dose groups immunization Infection inhibitory live SARS-CoV-2 Moderna mRNA mRNA-1273 mRNA-1273 vaccine nasal swab nasal swabs neutralization Neutralizing antibody titer neutralizing response PROTECT reduction reduction in Replication respiratory RNA SARS-CoV-2 serum dilution severe acute respiratory syndrome Coronavirus single dose These data two-dose regimen undetectable Vaccine variant variants of concern Viral [DOI] 10.1038/s41590-021-01021-0 PMC 바로가기 [Article Type] Article
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infectionsSARS-COV-2 델타 변형의 전염 사건은 다수의 백신 혁신 감염을 보여줍니다.Research Article Published on 2021-10-012022-09-10 Journal: BMC Medicine [Category] MERS, SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 allele allergy Alpha Alpha variant Amplicon Analysis B.1.617.2 BNT162b2 causal variant Chain Reaction circulating SARS-CoV-2 variants Cluster college coronavirus COVID-19 delta variant described determine filtered fraction funding GATK Genome global public health highest identify immune evasion Infection Infectious disease Infectious diseases Medicine Moderna mRNA-1273 nasopharyngeal swabs Panel Part Patient Pfizer polymerase chain polymerase chain reaction qPCR Quantitative quantitative polymerase chain reaction respiratory Result reveal risk SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 strain SARS-CoV-2 variant sequenced Sequencing severe acute respiratory syndrome Coronavirus supplementary material supported Swab tested toolkit Transmissibility Vaccine vaccine breakthrough infection variant Viral [DOI] 10.1186/s12916-021-02103-4 PMC 바로가기 [Article Type] Research Article
Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sitesObservational Study Published on 2021-10-012022-10-05 Journal: Journal of thrombosis and haemostasis : JTH [Category] SARS, 임상, [키워드] 95% CI 95% confidence interval adenoviral vector vaccine ADR Adverse drug reaction Analysis AstraZeneca cerebral vein thrombosis collected COVID-19 COVID-19 vaccinations COVID-19 vaccine database Europe European Medicines Agency expressed first dose greater highest incidence janssen lowest Moderna occurred raised released reported thrombocytopenia thrombosis thrombotic Vaccine Vaccines was performed [DOI] 10.1111/jth.15493 PMC 바로가기 [Article Type] Observational Study
Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaignLetter to the Editor Published on 2021-09-302022-10-31 Journal: Environmental health and preventive medicine [Category] COVID-19, SARS, [키워드] Administered adopted Adverse reactions Care carried collected composed concerning Coverage COVID-19 database development Dilution dose doses employment first dose Health profession healthcare worker hospital hygiene immunization Innovation management Moderna mRNA vaccine Nurses objective observation operative operators Pathways per day Pfizer professional protocol public health Result SARS-CoV-2 subject subjects target the SARS-CoV-2 the vaccine Treatment turnaround time unit vaccination Vaccination campaign Vaccine vaccine dose [DOI] 10.1186/s12199-021-01018-z PMC 바로가기 [Article Type] Letter to the Editor
Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 VaccineNeurology Published on 2021-09-262022-10-31 Journal: Cureus [Category] COVID-19, [키워드] adverse event appear association cerebrospinal fluid clinical symptom COVID-19 CSF Diagnosis effective Epidemiological study Evidence gbs following covid-19 vaccine gbs variant IMPROVE Infection prevention Moderna mRNA-1273 vaccine mRNA-based mRNA-based SARS-CoV-2 vaccine mRNA-based vaccine outcomes physician SARS-CoV-2 SARS-CoV-2 vaccine second dose Treatment [DOI] 10.7759/cureus.18291 PMC 바로가기 [Article Type] Neurology
Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 TransmissionSARS-COV-2 전송을 방지하는 백신의 수학적 모델링Article Published on 2021-09-242022-09-10 Journal: Viruses [Category] SARS, 변종, 치료기술, [키워드] airway airways average B.1.1.7 B.1.1.7 variant BNT162b2 clinical trial clinical trials COVID-19 decrease defined demonstrated disease Efficacy epidemic wave explained herd immunity Herd immunity threshold Infection King limit log mathematical mathematical model mathematical modeling Metrics modeling Moderna number of infected participant Pfizer-BioNTech predicted preventing infection PROTECT reached recipients reduction in SARS-CoV-2 SARS-CoV-2 vaccine secondary transmission spring Symptom symptomatic symptomatic COVID-19 the vaccine the vaccines Transmissibility Vaccine vaccine efficacy Vaccines Viral viral dynamics viral kinetics Viral load virus Washington [DOI] 10.3390/v13101921 PMC 바로가기 [Article Type] Article
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021Full Report Published on 2021-09-242022-10-30 Journal: Morbidity and Mortality Weekly Report [Category] COVID-19, [키워드] Comparative condition COVID-19 janssen Johnson & Johnson Moderna Pfizer-BioNTech Preventing United States [DOI] 10.15585/mmwr.mm7038e1 PMC 바로가기 [Article Type] Full Report
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies질병 변형 요법으로 치료받은 다발성 경화증 환자에서 SARS-CoV-2 mRNA 백신 접종의 효과Observational Study Published on 2021-09-222022-09-12 Journal: EBioMedicine [Category] MERS, 임상, 진단, [키워드] Affect analyzed anti-CD20 therapy anti-CD20 treatment antibody antigens assessments Blood blood collection BNT162b2 BNT162b2 vaccine Cellular immune response contribute coronavirus correlated decrease detectable disease Effect electrochemiluminescence immunoassay elicit evaluate the effect finding Follow-up funding humoral immune response Immunomodulatory therapies interval Italian Linear regression Moderna mRNA vaccination mRNA vaccine mRNA-1273 mRNA-based SARS-CoV-2 vaccines multicenter cohort study Multiple multiple sclerosis multivariable multivariable analysis Patient patients treated reduced SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 vaccine sclerosis second dose serological assessment significantly the vaccine therapy untreated patients vaccination Vaccine vaccine dose Vaccines [DOI] 10.1016/j.ebiom.2021.103581 PMC 바로가기 [Article Type] Observational Study